- Home
- VSTM vs ALF Comparison
VSTM vs ALF Comparison
Compare VSTM & ALF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSTM
- ALF
- Stock Information
- Founded
- VSTM 2010
- ALF 2024
- Country
- VSTM United States
- ALF United States
- Employees
- VSTM N/A
- ALF N/A
- Industry
- VSTM Biotechnology: Pharmaceutical Preparations
- ALF
- Sector
- VSTM Health Care
- ALF
- Exchange
- VSTM Nasdaq
- ALF NYSE
- Market Cap
- VSTM 425.9M
- ALF 379.1M
- IPO Year
- VSTM 2012
- ALF 2024
- Fundamental
- Price
- VSTM $4.93
- ALF $10.52
- Analyst Decision
- VSTM Strong Buy
- ALF
- Analyst Count
- VSTM 8
- ALF 0
- Target Price
- VSTM $12.71
- ALF N/A
- AVG Volume (30 Days)
- VSTM 2.6M
- ALF 211.2K
- Earning Date
- VSTM 08-07-2025
- ALF 01-01-0001
- Dividend Yield
- VSTM N/A
- ALF N/A
- EPS Growth
- VSTM N/A
- ALF N/A
- EPS
- VSTM N/A
- ALF 0.37
- Revenue
- VSTM $10,000,000.00
- ALF N/A
- Revenue This Year
- VSTM $129.06
- ALF N/A
- Revenue Next Year
- VSTM $306.32
- ALF N/A
- P/E Ratio
- VSTM N/A
- ALF $28.31
- Revenue Growth
- VSTM N/A
- ALF N/A
- 52 Week Low
- VSTM $2.10
- ALF $9.96
- 52 Week High
- VSTM $9.10
- ALF $10.60
- Technical
- Relative Strength Index (RSI)
- VSTM 30.80
- ALF N/A
- Support Level
- VSTM $5.73
- ALF N/A
- Resistance Level
- VSTM $6.62
- ALF N/A
- Average True Range (ATR)
- VSTM 0.46
- ALF 0.00
- MACD
- VSTM -0.17
- ALF 0.00
- Stochastic Oscillator
- VSTM 0.84
- ALF 0.00
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
About ALF CENTURION ACQUISITION CORP
Centurion Acquisition Corp is a blank check company.